Obesity - an epidemic of the 21st century – literature review
DOI:
https://doi.org/10.12775/JEHS.2024.70.49557Keywords
Obesity, Civilization disease, dyslipidemiaAbstract
Introduction and purpose: The article deals with the problem of obesity, which significantly increases the number of cases among children, adolescents and adults all over the world, leading to the occurrence of systemic disorders. A noticeable increase in the incidence of atherosclerosis, metabolic syndrome and diabetes leads to a reduction in life expectancy. The main aim of the work is to emphasize the seriousness of the contemporary problem, which causes impairment of the functioning of many systems. A secondary goal is to indicate the current standards of obesity treatment and how to deal with overweight.
Brief description of the state of knowledge: Obesity is a disease that affects nearly 800 million people around the world and affects every fourth Pole. Uncontrolled weight gain is caused; lifestyle changes, consumption of highly processed foods, and genetic and endocrine factors. It is a chronic disease with a tendency to relapse, with serious consequences and in need of diagnostics, personalized treatment, and often associated with psychological support.
Material and methods: The article analyzes the research to date and the latest treatment methods, which show that a person struggling with obesity is at risk of over 200 complications, including, for example, fatty liver, stroke, type 2 diabetes or cancer.
Results and conclusion: According to our analysis, obesity is a pathological condition that is truly life-threatening. Despite the society's downplay of the problem, people affected by this disease struggle with many comorbidities that worsen their quality of life.
References
World Health Organization: Obesity and overweight, [online] access 05.03.2024
TOMIAK E. Koziarska-Rościszewska M, Mizgała E, et al. Zasady postępowania w nadwadze i otyłości w praktyce lekarza rodzinnego. Wytyczne Kolegium Lekarzy Rodzinnych w Polsce, Polskiego Towarzystwa Medycyny Rodzinnej Polskiego Towarzystwa Badań Nad Otyłością, Łódź, 2014.
Kordecka A, Etiologia i Patogeneza, repozytorium Białostockiego Uniwersytetu Medycznego [online] access 05.03.2024
Jastreboff AM, Kotz CM, Kahan S, et al. Obesity as a disease: the obesity society 2018 position statement. Obesity, 2019, 27.1: 7-9.
Ralston J, Brinsden H, Buse K, et al. Time for a new obesity narrative. The Lancet, 2018, 392.10156: 1384-1386.
Tsigos C, Hainer V, Basdevant A, et al. Postępowanie w otyłości dorosłych: europejskie wytyczne dla praktyki klinicznej. Endokrynologia, Otyłość i Zaburzenia Przemiany Materii, 2009, 5.3: 87-98.
Jasiel-Wojculewicz H, Chrostowska M, Narkiewicz K, et al. Otyłość—niektóre aspekty epidemiologiczne i rokownicze. Kardiologia na co Dzień, 2007, 3.2: 79-83.
Czyżewski Ł. Nadwaga i otyłość jako czynniki ryzyka wystąpienia nadciśnienia tętniczego. Nursing Problems/Problemy Pielęgniarstwa, 2008, 16.1: 128-135.
Płaczkiewicz-Jankowska E, Czupryniak L, Strojek K, et al. Rozpoznawanie i leczenie otyłości. Omówienie zasad postępowania zgodnie z aktualnymi wytycznymi. Medycyna Praktyczna, 2021, 2.
Bryl W, Hoffmann K, Miczke A, et al. Otyłość w młodym wieku–epidemiologia, konsekwencje zdrowotne, konieczność prewencji. Przew. Lek, 2006, 9: 91-95.
Dyba J, Surdacka A, Otyłość – epidemia XXI wieku. Polish Dental Association.
Jopek S, Profil kwasów tłuszczowych we krwi a parametry metaboliczne u pacjentów otyłych. 2020.
Przybylska D, Kurowska M, Przybylski P, Otyłość i nadwaga w populacji rozwojowej. Hygeia public health, 2012, 47.1: 28-35.
Ahima RS, et al. Digging deeper into obesity. The Journal of clinical investigation, 2011, 121.6: 2076-2079.
Kazimierska I, Otyłość to choroba,nie defekt estetyczny. Kurier Medyczny, 2021.2: 14-15.
Czerwińska E, Walicka M, Marcinowska-Suchowierska E, Obesity–is always primary?. Postępy Nauk Medycznych, 2013.
Tatoń J, Kowrach M, Kuczerowski R. Kliniczna charakterystyka zespołu metabolicznego. Przewodnik Lekarza/Guide for GPs, 2003, 6.4: 58-65.
Consultation WHO, Obesity: preventing and managing the global epidemic. World Health Organization technical report series, 2000, 894: 1-253.
Zierle-Ghosh A, Jan A, Physiology, Body Mass Index. 2018.
Gosal D, Firmansyah Y, Ernawati E. Age, Body Weight, Body Mass Index, and Sleep Duration In Predicting Hypertension Incidence At Productive Age in Medan City. Jurnal Medika Hutama, 2021, 2.02: 537-550.
Szymocha M, Bryła M, Maniecka-Bryła I, Epidemia otyłości w XXI wieku. Zdrowie Publiczne, 2009, 119.2: 207-212.
Branca F, Nikogosian H, Lobstein T, The challenge of obesity in the WHO European Region and the strategies for response: summary. World Health Organization, 2007.
Kłosiewicz-Latoszek L,Cybulska B, Cukier a ryzyko otyłości, cukrzycy i chorób sercowo-naczyniowych. Problemy Higieny i Epidemiologii, 2011, 92.2: 181-186.
Drewnowski A, Bellisle F, Liquid calories, sugar, and body weight. The American journal of clinical nutrition, 2007, 85.3: 651-661.
Olsen NJ, Heitmann BL, intake of calorically sweetened beverages and obesity. Obesity reviews, 2009, 10.1: 68-75.
Farooqi IS, O'Rahilly S, Monogenic obesity in humans. Annu. Rev. Med., 2005, 56: 443-458.
Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nature genetics, 2007, 39.6: 724-726.
Wardle J, Carnell S, Haworth C, Obesity associated genetic variation in FTO is associated with diminished satiety. The Journal of Clinical Endocrinology & Metabolism, 2008, 93.9: 3640-3643.
Obuchowicz A, Epidemiologia nadwagi i otyłości-narastającego problemu zdrowotnego w populacji dzieci i młodzieży. Endokrynologia, Otyłość i Zaburzenia Przemiany Materii, 2005, 1.3: 9-12.
Szadkowska A Bodalski J, Otyłość u dzieci i młodzieży. Przewodnik Lekarza/Guide for GPs, 2003, 6.9: 54-58.
Montague CT, O'Rahilly S, The perils of portliness: causes and consequences of visceral adiposity. Diabetes, 2000, 49.6: 883-888.
Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension, 2003, 42.5: 878-884.
Alemán JO, Eusebi LH, Ricciardiello L, et al. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology, 2014, 146.2: 357-373.
Błogowski W, Ratajczak MZ, Żyżniewska‐Banaszak E, et al. Adipose tissue as a potential source of hematopoietic stem/progenitor cells. Obesity, 2012, 20.5: 923-931.
Harvey AE, Lashinger LM, Hursting SD, The growing challenge of obesity and cancer: an inflammatory issue. Annals of the New York Academy of Sciences, 2011, 1229.1: 45-52.
Hegde SR, Sun W, Lynch JP, Systemic and targeted therapy for advanced colon cancer. Expert review of gastroenterology & hepatology, 2008, 2.1: 135-149.
Hu G, Tuomilehto J, Silventoinen K, et al. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Archives of internal medicine, 2007, 167.13: 1420-1427.
Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. Jama, 1994, 272.3: 205-211.
Hahn S, Benson S, Elsenbruch S, et al. Metformin treatment of polycystic ovary syndrome improves health related quality-of-life and sexuality. Experimental and Clinical Endocrinology & Diabetes, 2006, 114.S 1: P07_097.
Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: prevalence and trends, 1960–1994. International journal of obesity, 1998, 22.1: 39-47.
Slentz CA, Duscha BD, Johnson JL, et al. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE—a randomized controlled study. Archives of internal medicine, 2004, 164.1: 31-39.
Gajewski P, Szczeklik A. Interna Szczeklika. Podręcznik chorób wewnętrznych.2013, 1402-1407.
Pietrobelli A, Heymsfield SB, Establishing body composition in obesity. Journal of endocrinological investigation, 2002, 25.10: 884-892.
Borysiak K, Broś A, Czekaj A. Borysiak, K., Zdrowie Kobiet w Polsce w latach, Urząd Statystyczny w Krakowie, [on-line] http://www. stat. gov. pl. 2004-2009
Choi LS, Jo IG, Kang KS, et al. Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity. International Journal of Obesity, 2021, 45.1: 130-142.
Olszanecka-Glinianowicz M, Filipiak KJ, Narkiewicz K, et al. Stanowisko Zespołu Ekspertów dotyczące zastosowania produktu leczniczego Mysimba®(chlorowodorek bupropionu i chlorowodorek naltreksonu) we wspomaganiu leczenia otyłości i nadwagi (BMI≥ 27 kg/m2) z chorobami towarzyszącymi. Choroby Serca i Naczyń, 2016, 13.5: 333-346.
Arterburn DE, Olsen MK, et al. Association between bariatric surgery and long-term health care expenditures among veterans with severe obesity. JAMA surgery, 2019, 154.12: e193732-e193732.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Klaudia Kułak, Izabela Sztybór, Katarzyna Kamińska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 603
Number of citations: 0